India · Delayed Price · Currency is INR Neuland Laboratories Statistics
Total Valuation
NSE:NEULANDLAB has a market cap or net worth of INR 284.74 billion. The enterprise value is 286.99 billion.
| Market Cap | 284.74B |
| Enterprise Value | 286.99B |
Important Dates
The last earnings date was Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
| Current Share Class | 12.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 11.30% |
| Owned by Institutions (%) | 20.16% |
| Float | 7.05M |
Valuation Ratios
The trailing PE ratio is 57.20 and the forward PE ratio is 55.34.
| PE Ratio | 57.20 |
| Forward PE | 55.34 |
| PS Ratio | 12.01 |
| PB Ratio | 15.19 |
| P/TBV Ratio | 17.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 82.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 57.65 |
| EV / Sales | 12.10 |
| EV / EBITDA | 37.53 |
| EV / EBIT | 42.83 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | -5.97 |
| Interest Coverage | 31.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 23.74% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 2.51% |
| Revenue Per Employee | 10.86M |
| Profits Per Employee | 2.28M |
| Employee Count | 2,183 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:NEULANDLAB has paid 1.71 billion in taxes.
| Income Tax | 1.71B |
| Effective Tax Rate | 25.62% |
Stock Price Statistics
The stock price has increased by +69.60% in the last 52 weeks. The beta is -0.32, so NSE:NEULANDLAB's price volatility has been lower than the market average.
| Beta (5Y) | -0.32 |
| 52-Week Price Change | +69.60% |
| 50-Day Moving Average | 18,497.28 |
| 200-Day Moving Average | 15,833.09 |
| Relative Strength Index (RSI) | 70.76 |
| Average Volume (20 Days) | 93,882 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEULANDLAB had revenue of INR 23.72 billion and earned 4.98 billion in profits. Earnings per share was 388.01.
| Revenue | 23.72B |
| Gross Profit | 13.09B |
| Operating Income | 6.70B |
| Pretax Income | 6.69B |
| Net Income | 4.98B |
| EBITDA | 7.55B |
| EBIT | 6.70B |
| Earnings Per Share (EPS) | 388.01 |
Balance Sheet
The company has 766.70 million in cash and 3.01 billion in debt, with a net cash position of -2.25 billion.
| Cash & Cash Equivalents | 766.70M |
| Total Debt | 3.01B |
| Net Cash | -2.25B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.74B |
| Book Value Per Share | 1,461.02 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 3.47 billion and capital expenditures -3.97 billion, giving a free cash flow of -504.52 million.
| Operating Cash Flow | 3.47B |
| Capital Expenditures | -3.97B |
| Depreciation & Amortization | 845.14M |
| Net Borrowing | 603.66M |
| Free Cash Flow | -504.52M |
| FCF Per Share | n/a |
Margins
Gross margin is 55.18%, with operating and profit margins of 28.25% and 20.99%.
| Gross Margin | 55.18% |
| Operating Margin | 28.25% |
| Pretax Margin | 28.22% |
| Profit Margin | 20.99% |
| EBITDA Margin | 31.81% |
| EBIT Margin | 28.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 34.00, which amounts to a dividend yield of 0.18%.
| Dividend Per Share | 34.00 |
| Dividend Yield | 0.18% |
| Dividend Growth (YoY) | 183.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.19% |
| Earnings Yield | 1.75% |
| FCF Yield | -0.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:NEULANDLAB is 24,334.75, which is 9.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24,334.75 |
| Price Target Difference | 9.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 19.64% |
| EPS Growth Forecast (3Y) | 30.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |